Elsevier

Gene

Volume 141, Issue 1, 8 April 1994, Pages 39-46
Gene

Cloning and sequences of two macrolide-resistance-encoding genes from mycinamicin-producing Micromonospora griseorubida

https://doi.org/10.1016/0378-1119(94)90125-2Get rights and content

Abstract

Two macrolide-resistance determinants were cloned from a mycinamicin (Mm)-producing Micromonospora griseorubida strain in Streptomyces lividans and Streptomyces parvulus. One of the cloned genes, designated myrA, was cloned as a gene which conferred strong resistance to Mm and tyiosin (Ty), but not to erythromycin (Er) or josamycin (Jm) on S. lividans. Another gene, named myrB, was cloned as an ErRencoding gene which conferred MLS resistance (to macrolide, lincosamide and streptogramine B antibiotics) on S. parvulus. Both myrA and myrB were sequenced and the corresponding ORFs were determined. The deduced amino acid (aa) sequence of myrA showed no similarity to proteins in the available databases, suggesting that an unknown mechanism of macrolide resistance is exerted by the MyrA protein. The deduced aa sequence of myrB exhibited high similarity to 23S rRNA methyltransferases (MTases), such as ErmE and CarB, from a variety of microorganisms.

References (28)

  • V.A. Birmingham et al.

    Cloning and expression of a tylosin resistance gene from a tylosin-producing strain of Streptomyces fradiae

    Mol. Gen. Genet.

    (1986)
  • E. Cundliffe

    How antibiotic-producing organisms avoid suicide

    Annu. Rev. Microbiol.

    (1989)
  • J.K. Epp et al.

    Molecular cloning and expression of carbomycin biosynthetic and resistance genes from Streptomyces thermotolerans

  • J.F. Fierro et al.

    Involvement of cell impermeability in resistance to macrolides in some producer streptomycetes

    J. Antibiot.

    (1988)
  • Cited by (21)

    • Genetic characterization, mechanisms and dissemination risk of antibiotic resistance of multidrug-resistant Rothia nasimurium

      2021, Infection, Genetics and Evolution
      Citation Excerpt :

      Three different types of efflux pumps were detected: Type I efflux pumps are from the major facilitator superfamily (MFS) and included tetZ and cmx, with resistance to tetracyclines and chloramphenicols (Tauch et al. 2000; Tauch et al. 1998); Type II is from ATP-binding cassette transporter families (ABC) including pstB, with resistance to fluoroquinolones (Lu et al. 2014); Type III efflux pumps are from small multidrug resistance families (SMR) including qacEΔ1, with resistance to disinfectants (Shafaati et al., 2016). MBLs, mysA, and rpoB variants provide resistance to antibiotic beta-Lactams (Sacha et al. 2008), macrolides (Inouye et al. 1994), and rifamycins (Ergeshov et al. 2017). Additionally, the presence of four resistance-related protein sequences, including the Fe-S cluster assembly ATPase sufC, phage shock protein (pspB), cysteine synthase (Cys) and phosphomannomutase (PMM), were consistent with previous reports (Zuo, 2011).

    • Mode of Action and Resistance Mechanisms of Antimicrobial Macrolides

      2003, Macrolide Antibiotics: Chemistry, Biology, and Practice: Second Edition
    View all citing articles on Scopus
    View full text